1 Early phase (2 weeks, range 1–4 weeks) |
10 |
731 |
Risk Ratio (IV, Random, 95% CI) |
1.39 [1.03, 1.90] |
1.1 Short‐acting hypnotics |
2 |
153 |
Risk Ratio (IV, Random, 95% CI) |
1.18 [0.47, 2.92] |
1.2 Anxiolytics or long‐acting hypnotics |
9 |
578 |
Risk Ratio (IV, Random, 95% CI) |
1.45 [0.97, 2.18] |
2 Acute phase (8 weeks, range 5–12 weeks) |
7 |
383 |
Risk Ratio (IV, Random, 95% CI) |
1.27 [0.99, 1.63] |
2.1 Short‐acting hypnotics |
1 |
27 |
Risk Ratio (IV, Random, 95% CI) |
2.63 [0.14, 49.69] |
2.2 Anxiolytics or long‐acting hypnotics |
7 |
356 |
Risk Ratio (IV, Random, 95% CI) |
1.26 [0.96, 1.65] |
3 Continuous phase (> 12 weeks) |
1 |
52 |
Risk Ratio (IV, Random, 95% CI) |
1.31 [0.80, 2.16] |
3.1 Anxiolytics or long‐acting hypnotics |
1 |
52 |
Risk Ratio (IV, Random, 95% CI) |
1.31 [0.80, 2.16] |